XML 65 R50.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) $ in Thousands | 3 Months Ended | 9 Months Ended
--- | --- | ---
Dec. 28, 2019 USD ($) | Dec. 29, 2018 USD ($) | Dec. 28, 2019 USD ($) segment | Dec. 29, 2018 USD ($)
Segment Reporting [Abstract] |  |  |  |
Number of business units | segment |  |  | 3 |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | $ 257,064 | $ 244,923 | $ 742,720 | $ 707,670
Effect of exchange rates | (3,291) | (2,442) | (8,072) | (3,323)
Net revenues | 258,970 | 247,356 | 749,987 | 718,284
Operating (loss) income | 40,907 | 28,320 | 77,344 | 59,689
Effect of exchange rates | 2,521 | 2,133 | 7,791 | 7,782
Impairment of assets and related costs | 0 | 0 | (51,220) | (21,170)
Amortization | 5,772 | 6,131 | 17,681 | 18,667
PCS2 accelerated depreciation and related costs | (6,649) | (4,822) | (18,708) | (13,203)
Gain on sale of assets | 0 | 0 | 8,083 | 0
Restructuring and turnaround costs | (7,798) | (1,791) | (13,582) | (7,258)
European Medical Device Regulation costs | (448) | 0 | (1,005) | 0
Other | 0 | (1,614) | 701 | (2,289)
United States |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 167,238 | 157,457 | 485,493 | 452,523
Japan |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 19,268 | 17,734 | 55,111 | 52,295
Europe |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 40,984 | 40,977 | 115,811 | 119,075
Asia |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 29,436 | 29,166 | 88,269 | 89,136
Other |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 2,044 | 2,022 | 5,303 | 5,255
Service |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 5,197 | 4,875 | 15,339 | 13,937
Plasma products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 141,231 | 131,823 | 406,825 | 373,078
Blood Center products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 66,126 | 67,155 | 191,648 | 199,881
Hospital products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 51,613 | 48,378 | 151,514 | 145,325
Plasma |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 120,997 | 112,738 | 348,141 | 318,878
Blood Center |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 85,314 | 84,775 | 246,977 | 248,106
Hospital |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 50,753 | 47,410 | 147,602 | 140,686
Operating Segments |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating (loss) income | 122,133 | 106,774 | 351,328 | 310,672
Operating Segments | Plasma |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating (loss) income | 59,343 | 47,133 | 169,844 | 133,661
Operating Segments | Blood Center |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating (loss) income | 42,197 | 41,478 | 121,124 | 121,005
Operating Segments | Hospital |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating (loss) income | 20,593 | 18,163 | 60,360 | 56,006
Corporate |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Corporate expenses | $ (63,080) | $ (66,229) | $ (188,363) | $ (196,178)

X
- Definition Corporate Operating Expenses + References No definition available. + Details
Name: | hae_CorporateOperatingExpenses
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Effect of Exchange Rate on Revenues + References No definition available. + Details
Name: | hae_EffectofExchangeRateonRevenues
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Effect of Exchange Rates on Operating Income + References No definition available. + Details
Name: | hae_EffectofExchangeRatesonOperatingIncome
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition European Medical Device Regulation Costs + References No definition available. + Details
Name: | hae_EuropeanMedicalDeviceRegulationCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net Revenues, Before Foreign Exchange Impact + References No definition available. + Details
Name: | hae_NetRevenuesBeforeForeignExchangeImpact
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Restructuring and Turnaround Costs + References No definition available. + Details
Name: | hae_RestructuringandTurnaroundCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_AdjustmentForAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_GainLossOnDispositionOfAssets1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References No definition available. + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. + References No definition available. + Details
Name: | us-gaap_OtherOperatingIncomeExpenseNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a)) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_ProductionRelatedImpairmentsOrCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan. + References No definition available. + Details
Name: | us-gaap_RestructuringReserveAcceleratedDepreciation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=hae_OtherCountryorRegionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_PlasmaProductsandServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_BloodCenterProductsandServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_HospitalProductsandServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |